ObsEva SA to Participate in JP Morgan Healthcare Conference January 8 - 11, 2018
Geneva, Switzerland and Boston, MA - January 5, 2018- ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's …